360 related articles for article (PubMed ID: 24071011)
21. TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract.
Wang X; Lopez-Beltran A; Osunkoya AO; Wang M; Zhang S; Davidson DD; Emerson RE; Williamson SR; Tan PH; Kaimakliotis HZ; Baldridge LA; MacLennan GT; Montironi R; Cheng L
Future Oncol; 2017 Apr; 13(8):705-714. PubMed ID: 28052688
[TBL] [Abstract][Full Text] [Related]
22. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
Gunia S; Erbersdobler A; Koch S; Otto W; Staibano S; D'Alterio C; Brookman-May S
Hum Pathol; 2013 May; 44(5):712-7. PubMed ID: 23158209
[TBL] [Abstract][Full Text] [Related]
23. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy.
Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A
Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107
[TBL] [Abstract][Full Text] [Related]
25. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
Zhao M; Williamson SR; Yu J; Xia W; Li C; Zheng J; Zhu Y; Sun K; Wang Z; Cheng L
Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894
[TBL] [Abstract][Full Text] [Related]
26. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
27. Strong androgen receptor expression is not useful in distinguishing GATA3 + metastases.
Lionti S; La Rocca L; Nunnari CM; Barresi V
Pathol Res Pract; 2018 Dec; 214(12):2110-2114. PubMed ID: 30293951
[TBL] [Abstract][Full Text] [Related]
28. Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas.
Malouf GG; Compérat E; Yao H; Mouawad R; Lindner V; Rioux-Leclercq N; Verkarre V; Leroy X; Dainese L; Classe M; Descotes JL; Barthelemy P; Yacoub M; Rouprêt M; Bernhard JC; Creighton CJ; Spano JP; Su X; Khayat D
Sci Rep; 2016 Aug; 6():30988. PubMed ID: 27484008
[TBL] [Abstract][Full Text] [Related]
29. Collision Tumor of Urothelial Cell Carcinoma and Clear Cell Renal Cell Carcinoma: A Case Report and Review of the Contemporary Literature.
Griffin J; Tahir F
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):e82-e86. PubMed ID: 30672774
[TBL] [Abstract][Full Text] [Related]
30. Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma.
Wang Y; Zhang J; Wang Y; Wang S; Zhang Y; Miao Q; Gao F; He H
Front Med; 2019 Dec; 13(6):730-740. PubMed ID: 31020542
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (ΔNp63) in squamous cell and urothelial carcinoma.
Gailey MP; Bellizzi AM
Am J Clin Pathol; 2013 Dec; 140(6):872-80. PubMed ID: 24225756
[TBL] [Abstract][Full Text] [Related]
32. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
Agarwal H; Babu S; Rana C; Kumar M; Singhai A; Shankhwar SN; Singh V; Sinha RJ
Indian J Pathol Microbiol; 2019; 62(2):244-250. PubMed ID: 30971548
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis of PAX8 expression in human epithelial tumors.
Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
[TBL] [Abstract][Full Text] [Related]
36. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
Fatima N; Osunkoya AO
Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic impact of p63 immunoreactivity in renal malignancies.
Tuna B; Unlu M; Aslan G; Secil M; Yorukoglu K
Anal Quant Cytol Histol; 2009 Apr; 31(2):118-22. PubMed ID: 19402389
[TBL] [Abstract][Full Text] [Related]
38. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
So JS; Epstein JI
Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
[TBL] [Abstract][Full Text] [Related]
39. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.
Langner C; Ratschek M; Tsybrovskyy O; Schips L; Zigeuner R
J Histochem Cytochem; 2003 Aug; 51(8):1097-9. PubMed ID: 12871991
[TBL] [Abstract][Full Text] [Related]
40. PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with b cells and tumors of pancreatic origin.
Tacha D; Qi W; Zhou D; Bremer R; Cheng L
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):59-63. PubMed ID: 22595948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
